Total Payments
$2,709
2024 Payments
$21.76
Companies
9
Transactions
37
Medicare Patients
2,628
Medicare Billing
$305,312
Payment Breakdown by Category
Food & Beverage$2,703 (99.8%)
Education$6.02 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,703 | 36 | 99.8% |
| Education | $6.02 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $994.81 | 14 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $681.39 | 8 | $0 (2019) |
| Novo Nordisk Inc | $458.18 | 5 | $0 (2023) |
| PFIZER INC. | $392.61 | 5 | $0 (2020) |
| Kowa Pharmaceuticals America, Inc. | $99.91 | 1 | $0 (2018) |
| UCB, Inc. | $22.74 | 1 | $0 (2017) |
| Allergan Inc. | $22.10 | 1 | $0 (2017) |
| Lilly USA, LLC | $21.76 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $15.60 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.76 | 1 | Lilly USA, LLC ($21.76) |
| 2023 | $174.29 | 2 | AstraZeneca Pharmaceuticals LP ($96.95) |
| 2022 | $175.94 | 2 | AstraZeneca Pharmaceuticals LP ($175.94) |
| 2021 | $325.34 | 4 | AstraZeneca Pharmaceuticals LP ($325.34) |
| 2020 | $450.51 | 8 | AstraZeneca Pharmaceuticals LP ($218.23) |
| 2019 | $643.59 | 7 | Novo Nordisk Inc ($281.65) |
| 2018 | $589.75 | 7 | Janssen Pharmaceuticals, Inc ($279.93) |
| 2017 | $327.92 | 6 | Janssen Pharmaceuticals, Inc ($206.02) |
All Payment Transactions
37 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Diabetes | ||||||
| 09/28/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $96.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $77.34 | General |
| 05/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $82.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/23/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $93.10 | General |
| Category: Respiratory | ||||||
| 11/11/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $106.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $107.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/16/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $99.84 | General |
| Category: Respiratory | ||||||
| 02/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: Respiratory | ||||||
| 03/04/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $95.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/20/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $99.19 | General |
| Category: Diabetes | ||||||
| 02/13/2020 | PFIZER INC. | COLOGUARD (Device) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: GASTROINTESTINAL | ||||||
| 02/11/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/06/2020 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: RESPIRATORY | ||||||
| 01/30/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $9.22 | General |
| Category: Respiratory | ||||||
| 01/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/14/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $95.44 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/07/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $68.44 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/15/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $93.68 | General |
| Category: Diabetes | ||||||
| 09/05/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $94.73 | General |
| Category: Diabetes | ||||||
| 02/21/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $93.24 | General |
| Category: Diabetes | ||||||
| 02/06/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $98.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/16/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 474 | 881 | $83,275 | $44,410 |
| 2022 | 19 | 635 | 1,242 | $141,453 | $71,459 |
| 2021 | 19 | 704 | 1,394 | $170,710 | $87,350 |
| 2020 | 21 | 815 | 1,625 | $209,367 | $102,092 |
Total Patients
2,628
Total Services
5,142
Medicare Billing
$305,312
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 230 | $33,790 | $18,216 | 53.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 130 | $15,830 | $7,312 | 46.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $7,552 | $5,127 | 67.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 41 | 43 | $7,615 | $4,137 | 54.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $5,290 | $2,598 | 49.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 33 | 39 | $4,760 | $2,282 | 47.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 21 | $2,160 | $1,121 | 51.9% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 23 | 23 | $805.00 | $770.27 | 95.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 55 | 120 | $820.00 | $762.72 | 93.0% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 52 | 56 | $1,480 | $734.72 | 49.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 24 | 24 | $648.00 | $635.04 | 98.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 25 | 94 | $1,510 | $361.90 | 24.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 23 | 37 | $1,015 | $352.24 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 257 | $37,265 | $19,721 | 52.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 67 | $26,800 | $10,419 | 38.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 149 | $17,880 | $7,748 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 52 | 52 | $9,100 | $6,295 | 69.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 46 | 53 | $9,275 | $5,057 | 54.5% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 11 | 44 | $6,820 | $4,286 | 62.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 27 | $6,750 | $3,552 | 52.6% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 20 | $4,200 | $3,042 | 72.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 37 | 47 | $5,640 | $2,353 | 41.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 30 | $3,000 | $1,703 | 56.8% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 11 | 12 | $3,000 | $1,476 | 49.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 19 | $2,850 | $1,185 | 41.6% |
About Dr. Miranda Decker, MD
Dr. Miranda Decker, MD is a Internal Medicine healthcare provider based in Russellville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1699967612.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Miranda Decker, MD has received a total of $2,709 in payments from pharmaceutical and medical device companies, with $21.76 received in 2024. These payments were reported across 37 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($2,703).
As a Medicare-enrolled provider, Decker has provided services to 2,628 Medicare beneficiaries, totaling 5,142 services with total Medicare billing of $305,312. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Russellville, AL
- Active Since 08/14/2007
- Last Updated 10/25/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1699967612
Products in Payments
- FARXIGA (Drug) $681.33
- XARELTO (Drug) $475.37
- ELIQUIS (Drug) $370.56
- Ozempic (Drug) $286.11
- INVOKANA (Drug) $206.02
- BREZTRI (Drug) $192.94
- BEVESPI AEROSPHERE (Drug) $99.93
- Livalo (Drug) $99.91
- Tresiba (Drug) $94.73
- Briviact (Drug) $22.74
- TEFLARO (Drug) $22.10
- COLOGUARD (Device) $22.05
- MOUNJARO (Drug) $21.76
- SYMBICORT (Drug) $20.61
- ANORO ELLIPTA (Drug) $15.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Russellville
Dr. Surbhi Chamaria, Md, MD
Internal Medicine — Payments: $8,559
Internal Medicine $8,559
Dr. Kamal Singh, Md, MD
Internal Medicine — Payments: $6,709
Internal Medicine $6,709
Dr. John Almirol, M.d, M.D
Internal Medicine — Payments: $5,422
Internal Medicine $5,422
Dr. Kushal Singh, Md, MD
Internal Medicine — Payments: $5,042
Internal Medicine $5,042
Keith Ison, Md, MD
Internal Medicine — Payments: $543.34
Internal Medicine $543.34
Homer Beavers, Md, MD
Internal Medicine — Payments: $486.45
Internal Medicine $486.45